Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in the Utilization of Prenatal Diagnosis

1 Jun 2004

Abstract excerpt

OBJECTIVE: The impact of prenatal screening for Down syndrome has largely been assessed under the assumption that screening protocols and policies are fully used. To measure the overall effectiveness in actual clinical practice, we analyzed the tests performed by a single cytogenetics laboratory. METHODS: We reviewed all amniotic fluid and chorionic villus samples (CVS) processed by the University of Connecticut...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down syndrome and intellectual disability research
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15172861
DOI: 10.1097/01.aog.0000127008.14792.14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in the Utilization of Prenatal DiagnosisPMID 15172861Read ↗

Trends in prenatal screening and diagnostic testing among women referred for advanced maternal ageSemantic proximity Read ↗

Use of the genetic sonogram in the United States in 2001 and 2007.Semantic proximity Read ↗

Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free beta hCG: a seven year reviewSemantic proximity Read ↗

Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersSemantic proximity Read ↗

[Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].Semantic proximity Read ↗

Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalitiesSemantic proximity Read ↗

Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013Semantic proximity Read ↗

Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patientsSemantic proximity Read ↗

Follow up and evaluation of the Victorian first‐trimester combined screening programme for Down syndrome and trisomy 18Semantic proximity Read ↗

The imprecision in rates of down syndrome by 1‐year maternal age intervals: A critical analysis of rates used in biochemical screeningSemantic proximity Read ↗

The price of abandoning diagnostic testing for cell‐free fetal DNA screeningSemantic proximity Read ↗

Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.